<DOC>
	<DOCNO>NCT02915211</DOCNO>
	<brief_summary>To evaluate tolerance , acceptability compliance Keyo 20 subject age 3 year , intractable epilepsy Glut-1 DS KD .</brief_summary>
	<brief_title>Evaluation Keyo Children With Epilepsy</brief_title>
	<detailed_description>Qualitative assessment subject questionnaire allow evaluation acceptability ease use study product . Collection daily data gastro-intestinal tolerance study product . Collection daily data compliance study product i.e . actual versus prescribe intake . Improve quality life increase range food available use ketogenic diet .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<mesh_term>Carbohydrate Metabolism , Inborn Errors</mesh_term>
	<criteria>3 year Confirmed diagnosis intractable epilepsy Glut1 DS Children must currently establish KD least 3 month , take orally Written , inform consent participant/carer</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Glut</keyword>
	<keyword>Ketogenic</keyword>
	<keyword>Glucose</keyword>
</DOC>